Boehringer Ingelheim (Canada) Ltd./Ltée07 September 2016

A world leader in equine respiratory disease prevention and treatment....

For over 20 years, Boehringer Ingelheim (Canada) Ltd./Ltée has been helping veterinarians and horse owners prevent and treat equine respiratory diseases.


Proud partner of Equine Canada

 

Calvenza® - the market leading equine respiratory vaccine

Calvenza® is an example of our commitment to respiratory disease prevention. Calvenza® has been shown to provide protection against both equine influenza (EIV) and equine herpes virus (EHV) and remains the ONLY vaccine in North America to have demonstrated efficacy under severe challenge at 6 and 12 months after vaccination. Calvenza® is supported by our Vaccine Assurance and Support Program.

Click here to view our Vaccine Assurance and Support Program.


VeteraTM - new combination vaccines including West Nile virus

 

VeteraTM vaccines include many combinations of West Nile virus, Eastern and Western Encephalitis, Influenza, Equine Herpes virus and Tetanus. The VeteraTM line of vaccines is safe, up-to-date and convenient fitting with all vaccine protocols. VeteraTM vaccines are supported by our Vaccine Assurance and Support Program.

Click here for more information on West Nile virus, Eastern and Western Encephalitis and Tetanus.

Click here for information on our Vaccine Assurance and Support Program.

Product Information

Click here to view our Boehringer Ingelheim (Canada) Ltd. Compendium of Product Monographs.  This information is intended for Canadian Veterinarians and their customers.